Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI
Clinical trial NCT04829019 · UNKNOWN
Trial details
- NCT number
- NCT04829019
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-07
- Primary completion
- 2024-04-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.